Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Overhof

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Physical Review Letters|March 5, 2004
Ab initio calculation of hyperfine and superhyperfine interactions for shallow donors in semiconductorsHarald Overhof, Uwe Gerstmann
Waste Management (New York, N.Y.)|October 4, 2011
Artificial lightweight aggregates as utilization for future ashes - A case studyAngelo Sarabèr, Robert Overhof, Terry Green, et al.
Magnetic Resonance in Chemistry : MRC|October 20, 2005
High-field optically detected EPR and ENDOR of semiconductor defects using W-band microwave Fabry-Pérot resonatorsJ-M Spaeth, I Tkach, S Greulich-Weber, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1992
Allo and auto crossmatches after transplantationE van den Berg-Loonen, R Overhof, M Tillemans, et al.
Brain : a Journal of Neurology|February 25, 2005
Motor cortex excitability in focal epilepsies not including the primary motor area--a TMS studyH M Hamer, J Reis, H-H Mueller, et al.
Transplantation|March 4, 1998
Donor-specific antibodies after transplantation by flow cytometry: relative change in fluorescence ratio most sensitive risk factor for graft survivalM H Christiaans, R Overhof-de Roos, F Nieman, et al.
Transplantation|November 15, 1996
No advantage of flow cytometry crossmatch over complement-dependent cytotoxicity in immunologically well-documented renal allograft recipientsM H Christiaans, R Overhof, A ten Haaft, et al.
International Journal of Radiation Oncology, Biology, Physics|December 7, 2020
Toxicity of L19-Interleukin 2 Combined with Stereotactic Body Radiation Therapy: A Phase 1 StudyEvert Jan Van Limbergen, Ann Hoeben, Relinde I Y Lieverse, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Physical Review Letters|March 5, 2004
Ab initio calculation of hyperfine and superhyperfine interactions for shallow donors in semiconductorsHarald Overhof, Uwe Gerstmann
Waste Management (New York, N.Y.)|October 4, 2011
Artificial lightweight aggregates as utilization for future ashes - A case studyAngelo Sarabèr, Robert Overhof, Terry Green, et al.
Magnetic Resonance in Chemistry : MRC|October 20, 2005
High-field optically detected EPR and ENDOR of semiconductor defects using W-band microwave Fabry-Pérot resonatorsJ-M Spaeth, I Tkach, S Greulich-Weber, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1992
Allo and auto crossmatches after transplantationE van den Berg-Loonen, R Overhof, M Tillemans, et al.
Brain : a Journal of Neurology|February 25, 2005
Motor cortex excitability in focal epilepsies not including the primary motor area--a TMS studyH M Hamer, J Reis, H-H Mueller, et al.
Transplantation|March 4, 1998
Donor-specific antibodies after transplantation by flow cytometry: relative change in fluorescence ratio most sensitive risk factor for graft survivalM H Christiaans, R Overhof-de Roos, F Nieman, et al.
Transplantation|November 15, 1996
No advantage of flow cytometry crossmatch over complement-dependent cytotoxicity in immunologically well-documented renal allograft recipientsM H Christiaans, R Overhof, A ten Haaft, et al.
International Journal of Radiation Oncology, Biology, Physics|December 7, 2020
Toxicity of L19-Interleukin 2 Combined with Stereotactic Body Radiation Therapy: A Phase 1 StudyEvert Jan Van Limbergen, Ann Hoeben, Relinde I Y Lieverse, et al.
Pageof 1